To define and compare the distinct alterations in SL classes and species induced in SPTLC1-associated ALS and HSAN1 disease conditions, we analyzed SL profiles in variant-expressing cells and patient-derived plasma and fibroblasts. The gene discussed is SPTLC1; the disease is amyotrophic lateral sclerosis.